SentiAR Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$8.5M
- Investors
-
18
SentiAR General Information
Description
Developer of a 3D augmented reality holographic platform designed to create a real-time 3D holographic interface for surgical applications. The company's platform features real-time holographic visualization of the patient's actual anatomy using real-time data from catheters and 3D electroanatomic mapping systems, thereby enabling clinicians, radiologists, neurologists, and anesthetists to treat and analyze cardiac ablation therapy to treat arrhythmia patients.
Contact Information
Website
www.sentiar.comCorporate Office
- 212 North Kingshighway Boulevard
- Box Number 28, Suite 115
- Saint Louis, MO 63108
- United States
Corporate Office
- 212 North Kingshighway Boulevard
- Box Number 28, Suite 115
- Saint Louis, MO 63108
- United States
SentiAR Timeline
SentiAR Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC (Series B) | 11-Apr-2023 | $8.5M | Completed | Generating Revenue | ||
8. Early Stage VC (Series A) | 01-Dec-2021 | Completed | Generating Revenue | |||
7. Early Stage VC (Series A) | 01-Jan-2021 | Completed | Generating Revenue | |||
6. Seed Round | 16-Apr-2018 | Completed | Generating Revenue | |||
5. Early Stage VC (Series A) | 22-Feb-2018 | Cancelled | Product In Beta Test | |||
4. Grant | 01-Jan-2018 | Completed | Product In Beta Test | |||
3. Grant | 03-Nov-2017 | Completed | Product In Beta Test | |||
2. Seed Round | 31-Aug-2017 | $1.1M | $1.1M | Completed | Product In Beta Test | |
1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
SentiAR Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A-3 | ||||||||
Series A-2 | ||||||||
Series A-1 | 157,042 | $0.000010 | $1.91 | $1.91 | 1x | $1.91 | 1.61% | |
Series A | 2,120,261 | $0.000010 | $2.39 | $2.39 | 1x | $2.39 | 21.73% |
SentiAR Comparisons
Industry
Financing
Details
SentiAR Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Empatica | Venture Capital-Backed | Cambridge, MA | ||||
Augmedics | Venture Capital-Backed | Arlington Heights, IL | ||||
RealView | Venture Capital-Backed | Yokneam Illit, Israel | ||||
Osso VR | Venture Capital-Backed | San Francisco, CA | ||||
Medivis | Venture Capital-Backed | New York, NY |
SentiAR Patents
SentiAR Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230341932-A1 | Two-way communication between head-mounted display and electroanatomic system | Pending | 22-Apr-2022 | ||
US-11452477-B2 | Electrogram annotation system | Active | 25-Oct-2019 | ||
US-20210121089-A1 | Electrogram annotation system | Active | 25-Oct-2019 | ||
CA-3158776-A1 | Electrogram annotation system | Pending | 25-Oct-2019 | ||
EP-4049126-A1 | Electrogram annotation system | Pending | 25-Oct-2019 | G16H40/63 |
SentiAR Executive Team (5)
Name | Title | Board Seat |
---|---|---|
Berk Tas | Chief Executive Officer, President & Board Member | |
Jonathan Silva | Co-Founder, Chief Technology Officer & Board Member | |
Michael Southworth | Co-Founder, Lead Developer & Vice President of Technology | |
Jennifer Silva MD | Co-Founder, Chief Medical Officer & Board Member |
SentiAR Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Jennifer Silva MD | SentiAR | Co-Founder, Chief Medical Officer & Board Member | |
Jonathan Silva | SentiAR | Co-Founder, Chief Technology Officer & Board Member | |
Sean Churchill | Self | Board Member | |
Shlomo Shpun | Techwald Holding | Board Member | |
Warren Watson | Self | Board Member |
SentiAR Signals
SentiAR Investors (18)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Cultivate(MD) | Venture Capital | Minority | ||
MedVenture Partners (Japan) | Venture Capital | Minority | ||
QRM Capital | Venture Capital | Minority | ||
Harmonix Fund | Venture Capital | Minority | ||
Keiretsu Forum | Venture Capital | Minority |
SentiAR FAQs
-
When was SentiAR founded?
SentiAR was founded in 2017.
-
Who is the founder of SentiAR?
Jonathan Silva, Michael Southworth, Jennifer Silva MD, and James Howard are the founders of SentiAR.
-
Who is the CEO of SentiAR?
Berk Tas is the CEO of SentiAR.
-
Where is SentiAR headquartered?
SentiAR is headquartered in Saint Louis, MO.
-
What is the size of SentiAR?
SentiAR has 27 total employees.
-
What industry is SentiAR in?
SentiAR’s primary industry is Surgical Devices.
-
Is SentiAR a private or public company?
SentiAR is a Private company.
-
What is the current valuation of SentiAR?
The current valuation of SentiAR is
. -
What is SentiAR’s current revenue?
The current revenue for SentiAR is
. -
How much funding has SentiAR raised over time?
SentiAR has raised $17.2M.
-
Who are SentiAR’s investors?
Cultivate(MD), MedVenture Partners (Japan), QRM Capital, Harmonix Fund, and Keiretsu Forum are 5 of 18 investors who have invested in SentiAR.
-
Who are SentiAR’s competitors?
Empatica, Augmedics, RealView, Osso VR, and Medivis are some of the 8 competitors of SentiAR.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »